Stock NSTM NOVELSTEM INTERNATIONAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News NovelStem International Corp.

Equities

NSTM

US67001V1098

Delayed OTC Markets
Other stock markets
 09:57:38 2024-04-18 am EDT 		5-day change 1st Jan Change
0.06 USD 0.00% Intraday chart for NovelStem International Corp. 0.00% -4.61%
Apr. 01 NovelStem International Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 NovelStem International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NovelStem International Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
NovelStem International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
NovelStem International Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
NovelStem International Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
NOVELSTEM INTERNATIONAL CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
NOVELSTEM INTERNATIONAL CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Novelstem International Corp. Appoints Jan Loeb as President
CI
NOVELSTEM INTERNATIONAL CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
NovelStem International Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
NOVELSTEM INTERNATIONAL CORP. : Change in Directors or Principal Officers (form 8-K)
AQ
NovelStem International Corp. Elects Christine Jenkins as Chief Financial Officer
CI
NovelStem International Corp. Elects Jan Loeb as Principal Executive Officer
CI
NovelStem International Corp. Announces Management Changes
CI
NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing for Approval of its Stem-Cell Based Anti-Cancer Drug Resistance Diagnostic; NovelStem Initiates Process to Become Publicly-Reporting with S.E.C. and to Up-List its Shares
GL
NovelStem International Corp and Newstem Ltd. Announce New Research Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy and Covid-19 Resistance
CI
NovelStem International Corp.'s Equity Buyback announced on January 16, 2018, has expired.
CI
Hollywood Media Corp. will Change its Ticker to NSTM from HOLL
CI
Hollywood Media Corp. has Changed its Name to NovelStem International Corp
CI
Hollywood Media Corp. Announces Board Changes
CI
NewStem Ltd. announced that it expects to receive $4 million in funding from Hollywood Media Corp.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NSTM Stock
  4. News NovelStem International Corp.